WWM
NAGE

Willingdon Wealth Management’s Niagen Bioscience NAGE Stock Holding History

Willingdon Wealth Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$3K Hold
800
– – ﹤0.01% 255
2019
Q4 		$3K Hold
800
– – ﹤0.01% 314
2019
Q3 		$3K Hold
800
– – ﹤0.01% 327
2019
Q2 		$4K Hold
800
– – ﹤0.01% 268
2019
Q1 		$3K Buy
+800
New +$2.88K ﹤0.01% 295

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SA
Sycale Advisors New York $201M AUM 2.35% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Willingdon Wealth Management's NAGE Position: Q1 2020 in Review

Willingdon Wealth Management held its Niagen Bioscience (NAGE) position steady in Q1 2020 at 800 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Willingdon Wealth Management first reported a position in NAGE in Q1 2019 and has held it in 5 quarters since. The position peaked at $4K in Q2 2019. 61 funds tracked by Wall St. Rank hold NAGE as of Q1 2020.

  • Willingdon Wealth Management held 800 shares of Niagen Bioscience worth $3K as of Q1 2020.
  • Willingdon Wealth Management left its Niagen Bioscience share count unchanged in Q1 2020.
  • Niagen Bioscience made up ﹤0.01% of Willingdon Wealth Management's portfolio in Q1 2020, its #255 holding.
  • Willingdon Wealth Management first reported a position in Niagen Bioscience in Q1 2019 and has held it in 5 quarters since.
  • Willingdon Wealth Management's Niagen Bioscience position peaked at $4K in Q2 2019.
  • 61 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.